查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1804255

医药品包装的全球市场:各包装形式，各产品，各药物类型，各处方类型，各最终用途，各地区-市场规模，产业动态，机会分析，预测(2025年～2033年)

Global Pharmaceutical Packaging Market: Packaging Type, Product, Application, Prescription Type, End Use, Region-Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033
出版日期: | 出版商: Astute Analytica | 英文 333 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

医药包装是指用于在药品整个生命週期内进行包装和保护的材料和工艺。预计2024年医药包装市场规模约为1,770亿美元，反映了其在整个医疗保健产业的规模和重要性。预测显示，未来十年该市场将经历显着成长，到2033年将达到6,129亿美元。这意味着2025年至2033年的复合年增长率为14.8%，凸显了该行业的快速扩张和不断发展变化。

医药包装产业的空前成长是由多种关键因素共同推动的，其中最显着的是全球人口的快速成长和老化，这推动了对各种医药产品的需求成长。老年患者通常需要更复杂的治疗方案，通常涉及多种药物，因此需要先进的包装解决方案来提高安全性、易用性和服药顺从性。此外，糖尿病、心血管疾病和癌症等慢性疾病的发生率不断上升，也推动了对药物的持续需求。

值得关注的市场发展

医药包装市场高度分散，既有大型跨国公司，也有中型企业，还有许多规模较小的国内企业。国际纸业、WestRock Company 和 CCL Industries 等公司以提供折迭纸盒和其他二次包装材料而闻名。这些产品在储存和运输过程中保护初级包装，并向最终消费者提供重要的品牌和监管资讯方面发挥关键作用。

该市场近期的策略性举措显示了持续的整合和创新。例如，该领域的领导者 Alvotech 宣布收购瑞士 Ivers-Lee 集团，该公司专门从事药品组装和包装服务。此次收购将Ivers-Lee集团的业务策略性地整合到Alvotech的技术营运部门，增强其服务能力，同时保持Ivers-Lee作为独立法人实体的地位。

市场发展的创新也反映在环保包装解决方案的开发上。冷链技术公司（CCT）近期推出了路边回收包裹托运人产品组合，专为 "首英里" 包裹运输而设计。这款新产品确保对温度敏感的药品在运输过程中得到热保护，这是维持许多药物疗效的关键因素。

推动因素

随着全球65岁及以上人口的快速增长，老龄化社会正在显着改变医药包装市场。 2024年，该领域人口将达到约7.61亿，预计到2050年将翻倍。不断增长的老龄人口对医疗保健系统提出了巨大的需求，老年人的处方药消费量通常是年轻人的三倍左右。

辉瑞和诺华等製药公司强调了这一人口趋势的经济影响，并报告称，专门针对与年龄相关疾病的产品在全球范围内每年创造约4780亿美元的收入。这一巨大的市场价值反映出人们日益关注开发与老化相关的常见疾病的治疗方法，例如心血管疾病、关节炎、神经退化性疾病和骨质疏鬆症。

新兴市场趋势

仿製药彻底改变了新兴市场的医疗保健可近性，推动了医药包装市场前所未有的需求。自2020年以来，这些地区约有28亿人首次获得了基本药物，这主要归功于仿製药的广泛供应和可负担性。药物可及性的急剧增加迫使包装製造商扩大生产规模并创新解决方案，以满足这个不断扩大的市场日益多样化和不断增长的需求。

印度是全球仿製药产业的强国，生产约6万个仿製药品牌。为了支持如此大规模的生产，每年需要约450亿个包装，以满足该国庞大的国内人口和国际市场的需求。因此，印度的医药包装产业必须大规模运营，在大批量生产与严格的品质和监管标准之间取得平衡，才能安全地将药品运送到世界各地。

优化障碍

个人化医疗正在从根本上改变药品製造模式，为医药包装市场带来新的课题和机会。传统的大规模、统一的生产方式正在被高度专业化的流程所取代，这些流程必须适应针对个别患者量身定制的小规模生产。在某些情况下，这意味着每批只需生产100个包装，即可满足患者独特治疗的精确需求。

这种个人化趋势在CAR-T细胞疗法等先进疗法中特别明显，该疗法每年约有15,000名患者获准。这些疗法需要具有低温储存功能的个人化包装解决方案，不仅要确保安全性和有效性，还要保护精密的生物材料。此类专用患者试剂盒的单价可达12,000美元，这反映了其所需的复杂性和精确度。

市场区隔详情

按包装类型划分，初级包装占了72%的市场。创新先进包装增强了初级包装解决方案的安全性、完整性和功能性，进一步巩固了这一主导地位。其中最重要的创新之一是温度指示器的加入，当产品温度超出关键的2-8°C范围时，它会快速提供视觉提示。这些指示器在暴露于不适当温度后仅需12秒即可变色，从而可以立即检测到可能有问题的产品。

依应用划分，口服药品包装占医药包装市场的主导地位，占市场收入的33%。其中最显着的进步之一是配备高灵敏度重量感测器的智慧药瓶的开发，该感测器可以检测到药丸取出，精度高达0.1克。透过追踪服药时间和剂量，这些感测器能够准确监测患者的服药依从性，从而更好地管理治疗方案，尤其对于需要严格遵守处方剂量的慢性病患者。

依产品类型划分，塑胶包装占医药包装市场的主导地位，市占率为36%。这一领先地位主要归功于多层阻隔膜的突破，这些膜显着提高了敏感药品所需的保护性能。这些薄膜的设计旨在实现极低的水蒸气透过率，通常低于0.0001克/平方公尺/天，有效保护药品免受湿气相关的降解。

各市场区隔明细

医药品各类型

  • 一级药物
  • 二级药物
  • 三级药物

各产品

  • 瓦楞纸板
    • 箱子
    • 硬纸盒
    • 显示器个体
  • 纸
    • 标籤
    • 散页宣传印刷品
    • 玻璃
  • 安瓿
    • 瓶
    • 管瓶
    • 注射器
    • 滤芯
  • 塑胶
    • 封口装置
    • 瓶
    • 袋子
    • 管
    • 注入·托盘
    • 纸或箔附着层压板
  • 金属
    • 可折迭管
    • 硬质罐
    • 铝箔
    • 压力容器
  • 橡胶

各用途

  • 口服剂
  • 注射剂
  • 外用剂
  • 眼科用药
  • 经鼻子
  • 舌下
  • 肺
  • 经皮
  • 点滴药
  • 其他

各处方类型

  • 处方笺
    • 品牌药
    • 学名药
  • 一般用医药品
    • 品牌药
    • 学名药

各最终用途

  • 医药品製造
  • 受託包装
  • 零售药局
  • 机关药局

各地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 波兰
    • 俄罗斯
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲·纽西兰
    • ASEAN
      • 马来西亚
      • 新加坡
      • 泰国
      • 印尼
      • 菲律宾
      • 越南
      • 其他
    • 其他地区
  • 中东·非洲
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 其他

各地区明细

北美在医药包装市场占主导地位，占41%的市场占有率，这深深植根于生物技术集群。这些集群是创新中心，包装製造商和药品开发商在此密切合作开展研究项目，推动了针对药品特定需求的尖端包装解决方案的出现。

这项技术创新的核心是这些集群内的专业测试实验室，这些实验室配备了能够模拟极端条件的先进环境测试室。这些测试室可以重现各种环境，从-80°C的超低温（如专用冷冻柜中的温度）到40°C的高温和75%的相对湿度。这种能力可以快速、全面地验证包装性能，确保药品在各种储存和运输条件下的稳定性和安全性。

对先进製造技术的投资进一步巩固了北美在该市场的领先地位。仅在2024年，该地区就投资了72亿美元，用于升级包装设施，使其配备最先进的系统。这些技术创新包括基于人工智慧的品质控制系统，其运行速度比传统的人工检测快约340倍，显着提高了缺陷检测效率。

主要市场参与企业

  • Amcor
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Berry Global, Inc.
  • Catalent (US)
  • CCL Industries, Inc.
  • Comar, LLC
  • Drug Plastics Group
  • Gerresheimer AG
  • International Paper
  • Owens Illinois, Inc.
  • Schott AG
  • SGD Pharma
  • Vetter Pharma International
  • West Pharmaceutical Services, Inc.
  • WestRock Company
  • 其他的主要企业

目录

第1章 调查架构

第2章 调查手法

第3章 摘要整理:全球医药品包装市场

第4章 全球医药品包装市场概要

  • 产业价值链分析
    • 原料供应商
    • 厂商
    • 加工和包装
    • 贩卖代理店
    • 终端用户
  • 产业展望
    • 医药品包装的龙头企业和服务
  • 大环境分析
  • 波特的五力分析
  • 市场动态和趋势
  • COVID-19对市场成长趋势的影响评估
  • 市场成长与展望
  • 竞争仪表板

第5章 医药品包装市场(各包装形式)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 第一次
    • 第二次
    • 第三次

第6章 医药品包装市场(各产品)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 厚纸
    • 纸
    • 玻璃
    • 塑胶
    • 金属
    • 橡胶

第7章 医药品包装市场(各药物类型)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 口服药
    • 注射剂
    • 专题
    • 眼科
    • 鼻腔
    • 舌下
    • 肺
    • 经皮
    • 静脉内药
    • 其他

第8章 医药品包装市场(各处方类型)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 处方笺
    • 成药

第9章 医药品包装市场(各最终用途)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 医药品製造
    • 契约包装
    • 零售药局
    • 设施药局

第10章 医药品包装市场(各地区·各国)

  • 重要的洞察
  • 市场规模与预测，2020年～2033年(10亿美元)
    • 北美
    • 欧洲
    • 亚太地区
    • 中东·非洲
    • 南美

第11章 北美的医药品包装市场分析

第12章 美国的医药品包装市场分析

第13章 加拿大的医药品包装市场分析

第14章 欧洲的医药品包装市场分析

第15章 亚太地区的医药品包装市场分析

第16章 日本的医药品包装市场分析

第17章 ASEAN的医药品包装市场分析

第18章 中东·非洲的医药品包装市场分析

第19章 南美的医药品包装市场分析

第20章 企业简介

  • Amcor
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Berry Global, Inc.
  • Catalent(US)
  • CCL Industries, Inc.
  • Comar, LLC
  • Drug Plastics Group
  • Gerresheimer AG
  • International Paper
  • Owens Illinois, Inc.
  • Schott AG
  • SGD Pharma
  • Vetter Pharma International
  • West Pharmaceutical Services, Inc.
  • WestRock Company
  • 其他
简介目录
Product Code: AA1221110

Pharmaceutical packaging refers to the materials and processes utilized to enclose and safeguard medicinal products throughout their entire lifecycle. In 2024, the pharmaceutical packaging market was valued at approximately US$ 177.0 billion, reflecting its significant scale and importance within the broader healthcare industry. Projections indicate that this market will experience remarkable growth over the coming decade, with an anticipated valuation reaching US$ 612.9 billion by 2033. This forecast corresponds to a compound annual growth rate (CAGR) of 14.8% between 2025 and 2033, underscoring the rapid expansion and evolving dynamics within the sector.

The pharmaceutical packaging industry's unprecedented growth is driven by a convergence of several key factors. Foremost among these is the aging global population, which is expanding rapidly and increasing demand for a variety of medications. Older adults typically require more complex treatment regimens, often involving multiple drugs, which necessitates sophisticated packaging solutions designed to enhance safety, usability, and adherence. Additionally, the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is fueling sustained demand for pharmaceutical products.

Noteworthy Market Developments

The pharmaceutical packaging market is characterized by a high degree of fragmentation, consisting of a diverse mix of large multinational corporations, medium-sized enterprises, and numerous small domestic players. Firms such as International Paper, WestRock Company, and CCL Industries are notable for their offerings in folding cartons and other secondary packaging materials. These products play an essential role in protecting primary packaging during storage and transportation, as well as providing important branding and regulatory information to end consumers.

Recent strategic moves within the market underscore ongoing consolidation and innovation. For example, Alvotech, a key player in the sector, announced its acquisition of Ivers-Lee Group, a Swiss company specializing in pharmaceutical assembly and packaging services. This acquisition strategically integrates Ivers-Lee's operations into Alvotech's Technical Operations division, enhancing its service capabilities while preserving Ivers-Lee as a separate legal entity.

Innovation within the market is also evident in the development of environmentally conscious packaging solutions. Cold Chain Technologies (CCT) recently launched a curbside recyclable parcel shipper portfolio designed specifically for first-mile, parcel-sized shipments. This new product ensures that temperature-sensitive pharmaceutical products remain thermally protected during transit, a critical factor for maintaining the efficacy of many drugs.

Core Growth Drivers

The aging demographic shift is profoundly reshaping the pharmaceutical packaging market, driven by the rapid growth of the global population aged 65 and older. In 2024, this segment reached approximately 761 million individuals, and projections indicate it will double by 2050. This expanding elderly population places significantly greater demands on healthcare systems, as older adults typically consume about three times more prescription medications compared to younger age groups.

Pharmaceutical companies such as Pfizer and Novartis have underscored the economic impact of this demographic trend, reporting that products specifically targeting age-related conditions generate annual revenues of roughly US$ 478 billion globally. This substantial market value reflects the growing focus on developing treatments for diseases commonly associated with aging, including cardiovascular disorders, arthritis, neurodegenerative diseases, and osteoporosis.

Emerging Opportunity Trends

Generic medications have revolutionized healthcare accessibility across emerging markets, driving an unprecedented surge in demand within the pharmaceutical packaging market. Since 2020, approximately 2.8 billion people in these regions have gained first-time access to essential medicines, largely due to the widespread availability and affordability of generic drugs. This dramatic increase in access has created significant pressure on packaging manufacturers to scale up production and innovate solutions that meet the diverse and growing needs of these expanding markets.

India stands as a global powerhouse in the generic pharmaceutical sector, producing an estimated 60,000 generic drug brands. To support this massive output, the country requires around 45 billion packaging units annually, serving both its vast domestic population and international markets. India's pharmaceutical packaging industry must therefore operate on an enormous scale, balancing high-volume production with stringent quality and regulatory standards to ensure the safe delivery of medications worldwide.

Barriers to Optimization

Personalized medicine is fundamentally transforming pharmaceutical manufacturing paradigms, imposing new challenges and opportunities on the pharmaceutical packaging market. Traditional large-scale, uniform production methods are giving way to highly specialized processes that must accommodate small production runs tailored to individual patients. In some cases, this means producing as few as 100 units per batch to meet the precise requirements of patient-specific therapies.

This shift toward personalization is particularly evident in advanced treatments such as CAR-T cell therapies, which have gained approval for around 15,000 patients annually. These therapies necessitate individualized packaging solutions that not only ensure safety and efficacy but also provide cryogenic storage capabilities to maintain the delicate biological materials involved. The cost of these specialized patient kits can reach as high as US$ 12,000 each, reflecting the complexity and precision required.

Detailed Market Segmentation

By Packaging Type, the primary packaging segment holds a commanding 72% share of the market. This dominance is reinforced by revolutionary advancements that enhance the safety, integrity, and functionality of primary packaging solutions. One of the most significant innovations is the integration of embedded temperature indicators that provide rapid visual cues when products experience temperature excursions outside the critical 2-8°C range. These indicators can change color within just 12 seconds of exposure to improper temperatures, allowing for immediate detection of potential product compromise.

By Application, oral drug packaging holds a commanding position in the pharmaceutical packaging market, accounting for 33% of market revenue, largely due to groundbreaking patient-centric innovations. One of the most notable advancements is the development of smart pill bottles equipped with highly sensitive weight sensors capable of detecting medication removal with an accuracy of up to 0.1 grams. These sensors enable precise monitoring of patient adherence by tracking when and how much medication is taken, facilitating better management of treatment regimens, especially for individuals with chronic conditions who require strict adherence to prescribed dosages.

In terms of products, plastic packaging holds a dominant position in the pharmaceutical packaging market, commanding a significant 36% market share. This leadership is largely driven by groundbreaking advancements in multilayer barrier films, which have dramatically improved the protective qualities required for sensitive pharmaceutical products. These films are engineered to achieve exceptionally low water vapor transmission rates, often falling below 0.0001 grams per square meter per day, effectively safeguarding medications from moisture-related degradation.

Segment Breakdown

By Drug Type

  • Primary
  • Secondary
  • Tertiary

By Product

  • Cardboard
    • Boxes
    • Cartons
    • Display Unit
  • Paper
    • Label
    • Leaflet
    • Glass
  • Ampoules
    • Bottles
    • Vials
    • Syringes
    • Cartridges
  • Plastic
    • Closure
    • Bottles
    • Bags
    • Tubes
    • Injection Trays
    • Laminates with paper or foil
  • Metal
    • Collapsible tubes
    • Rigid cans
    • Foils
    • Pressurized containers
  • Rubber

By Application

  • Oral Drugs
  • Injectable
  • Topical
  • Ocular/ Ophthalmic
  • Nasal
  • Sublingual
  • Pulmonary
  • Transdermal
  • IV Drugs
  • Others

By Prescription Type

  • Prescription
    • Branded drugs
    • Generic drugs
  • OTC
    • Branded drugs
    • Generic drugs

By End-Use

  • Pharma Manufacturing
  • Contract Packaging
  • Retail Pharmacy
  • Institutional Pharmacy

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • The UK
    • Germany
    • France
    • Italy
    • Spain
    • Poland
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia & New Zealand
    • ASEAN
      • Malaysia
      • Singapore
      • Thailand
      • Indonesia
      • Philippines
      • Vietnam
      • Rest of ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of MEA
  • South America
    • Argentina
    • Brazil
    • Rest of South America

Geographical Breakdown

North America's dominance in the pharmaceutical packaging market, commanding a substantial 41% share, is deeply rooted in its concentrated biotechnology clusters. These clusters serve as innovation hubs where packaging manufacturers and drug developers collaborate closely on research initiatives, driving the emergence of cutting-edge packaging solutions tailored to the unique demands of pharmaceutical products.

Central to this innovation are specialized testing laboratories established within these clusters, equipped with advanced environmental chambers capable of simulating extreme conditions. These chambers can replicate environments ranging from ultra-low temperatures of -80°C, akin to those in specialized freezers, to high heat and humidity levels of 40°C and 75% relative humidity. This capability allows for rapid and thorough validation of packaging performance, ensuring that pharmaceutical products remain stable and secure under various storage and transportation conditions.

Investment in advanced manufacturing technologies further strengthens North America's leadership in this market. In 2024 alone, the region saw investments totaling US$ 7.2 billion directed toward upgrading packaging facilities with state-of-the-art systems. Among these innovations are artificial intelligence-powered quality control systems that dramatically enhance defect detection efficiency, operating approximately 340 times faster than traditional manual inspections.

Leading Market Participants

  • Amcor
  • AptarGroup, Inc.
  • Becton, Dickinson, and Company
  • Berry Global, Inc.
  • Catalent (US)
  • CCL Industries, Inc.
  • Comar, LLC
  • Drug Plastics Group
  • Gerresheimer AG
  • International Paper
  • Owens Illinois, Inc.
  • Schott AG
  • SGD Pharma
  • Vetter Pharma International
  • West Pharmaceutical Services, Inc.
  • WestRock Company
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1 Research Objective
  • 1.2 Product Overview
  • 1.3 Market Segmentation

Chapter 2. Research Methodology

  • 2.1 Qualitative Research
    • 2.1.1 Primary & Secondary Sources
  • 2.2 Quantitative Research
    • 2.2.1 Primary & Secondary Sources
  • 2.3 Breakdown of Primary Research Respondents, By Region
  • 2.4 Assumption for the Study
  • 2.5 Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Pharmaceutical Packaging Market

Chapter 4. Global Pharmaceutical Packaging Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Raw Material Supplier
    • 4.1.2. Manufacturer
    • 4.1.3. Processing and Packaging
    • 4.1.4. Distributors
    • 4.1.5. End User
  • 4.2. Industry Outlook
    • 4.2.1. Top pharmaceutical packaging companies and services
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Challenges
    • 4.5.4. Key Trends
  • 4.6. Covid-19 Impact Assessment on Market Growth Trend
  • 4.7. Market Growth and Outlook
    • 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2033
    • 4.7.2. Pricing Analysis
  • 4.8. Competition Dashboard
    • 4.8.1. Market Concentration Rate
    • 4.8.2. Company Market Share Analysis (Value %), 2024
    • 4.8.3. Competitor Mapping

Chapter 5. Pharmaceutical Packaging Market, By Packaging Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 5.2.1. Primary
    • 5.2.2. Secondary
    • 5.2.3. Tertiary

Chapter 6. Pharmaceutical Packaging Market, By Product

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 6.2.1. Cardboard

6.2.1.1. Boxes

6.2.1.2. Cartons

6.2.1.3. Display unit

    • 6.2.2. Paper

6.2.2.1. Label

6.2.2.2. Leaflet

    • 6.2.3. Glass

6.2.3.1. Ampoules

6.2.3.2. Bottles

6.2.3.3. Vials

6.2.3.4. Syringes

6.2.3.5. Cartridges

    • 6.2.4. Plastic

6.2.4.1. Closure

6.2.4.2. Bottles

6.2.4.3. Bags

6.2.4.4. Tubes

6.2.4.5. Injection Trays

6.2.4.6. Laminates with paper or foil

    • 6.2.5. Metal

6.2.5.1. Collapsible tubes

6.2.5.2. Rigid cans

6.2.5.3. Foils

6.2.5.4. Pressurized containers

    • 6.2.6. Rubber

Chapter 7. Pharmaceutical Packaging Market, By Drug Type

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 7.2.1. Oral Drugs
    • 7.2.2. Injectables
    • 7.2.3. Topical
    • 7.2.4. Ocular/ Ophthalmic
    • 7.2.5. Nasal
    • 7.2.6. Sublingual
    • 7.2.7. Pulmonary
    • 7.2.8. Transdermal
    • 7.2.9. IV Drugs
    • 7.2.10. Others

Chapter 8. Pharmaceutical Packaging Market, By Prescription Type

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 8.2.1. Prescription
      • 8.2.1.1. Branded Drugs
      • 8.2.1.2. Generic drugs
    • 8.2.2. OTC
      • 8.2.2.1. Branded Drugs
      • 8.2.2.2. Generic drugs

Chapter 9. Pharmaceutical Packaging Market, By End Use

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 9.2.1. Pharma Manufacturing
    • 9.2.2. Contract Packaging
    • 9.2.3. Retail Pharmacy
    • 9.2.4. Institutional Pharmacy

Chapter 10. Pharmaceutical Packaging Market, By Region/ Country

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 10.2.1. North America
      • 10.2.1.1. The U.S.
      • 10.2.1.2. Canada
      • 10.2.1.3. Mexico
    • 10.2.2. Europe
      • 10.2.2.1. The UK
      • 10.2.2.2 Germany
      • 10.2.2.3 France
      • 10.2.2.4. Spain
      • 10.2.2.5. Italy
      • 10.2.2.6. Russia
      • 10.2.2.7. Poland
      • 10.2.2.8. Rest of Europe
    • 10.2.3. Asia Pacific
      • 10.2.3.1. China
      • 10.2.3.2. India
      • 10.2.3.3. Japan
      • 10.2.3.4. Australia & New Zealand
      • 10.2.3.5. ASEAN
      • 10.2.3.6. Rest of Asia Pacific
    • 10.2.4. Middle East & Africa (MEA)
      • 10.2.4.1. UAE
      • 10.2.4.2. Saudi Arabia
      • 10.2.4.3. South Africa
      • 10.2.4.4. Rest of MEA
    • 10.2.5. South America
      • 10.2.5.1. Brazil
      • 10.2.5.2. Argentina
      • 10.2.5.3. Rest of South America

Chapter 11. North America Pharmaceutical Packaging Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 11.2.1. By Packaging Type
    • 11.2.2. By Product Type
    • 11.2.3. By Application
    • 11.2.4. By End Use
    • 11.2.5. By Prescription Type
    • 11.2.6. By Country

Chapter 12. The U.S. Pharmaceutical Packaging Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 12.2.1. By Packaging Type
    • 12.2.2. By Product Type
    • 12.2.3. By Application
    • 12.2.4. By End Use
    • 12.2.5. By Prescription Type

Chapter 13. Canada Pharmaceutical Packaging Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 13.2.1. By Packaging Type
    • 13.2.2. By Product Type
    • 13.2.3. By Application
    • 13.2.4. By End Use
    • 13.2.5. By Prescription Type

Chapter 14. Europe Pharmaceutical Packaging Market Analysis

  • 14.1. Key Insights
  • 14.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 14.2.1. By Packaging Type
    • 14.2.2. By Product Type
    • 14.2.3. By Application
    • 14.2.4. By End Use
    • 14.2.5. By Prescription Type
    • 14.2.5. By Country

Chapter 15. Asia Pacific Pharmaceutical Packaging Market Analysis

  • 15.1. Key Insights
  • 15.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 15.2.1. By Packaging Type
    • 15.2.2. By Product Type
    • 15.2.3. By Application
    • 15.2.4. By End Use
    • 15.2.5. By Prescription Type
    • 15.2.6. By Country

Chapter 16. Japan Pharmaceutical Packaging Market Analysis

  • 16.1. Key Insights
  • 16.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 16.2.1. By Packaging Type
    • 16.2.2. By Product Type
    • 16.2.3. By Application
    • 16.2.4. By End Use
    • 16.2.4. By Prescription Type

Chapter 17. ASEAN Pharmaceutical Packaging Market Analysis

  • 17.1. Key Insights
  • 17.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 17.2.1. By Packaging Type
    • 17.2.2. By Product Type
    • 17.2.3. By Application
    • 17.2.4. By End Use
    • 17.2.5. By Prescription Type
    • 17.2.6. By Country

Chapter 18. Middle East & Africa Pharmaceutical Packaging Market Analysis

  • 18.1. Key Insights
  • 18.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 18.2.1. By Packaging Type
    • 18.2.2. By Product Type
    • 18.2.3. By Application
    • 18.2.4. By End Use
    • 18.2.5. By Prescription Type
    • 18.2.6. By Country

Chapter 19. South America Pharmaceutical Packaging Market Analysis

  • 19.1. Key Insights
  • 19.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
    • 19.2.1. By Packaging Type
    • 19.2.2. By Product Type
    • 19.2.3. By Application
    • 19.2.4. By End Use
    • 19.2.5. By Prescription Type
    • 19.2.6. By Country

Chapter 20. Company Profile (Company Overview, Financial Matrix, Sales Composition Ration, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 20.1. Amcor
  • 20.2. AptarGroup, Inc.
  • 20.3. Becton, Dickinson, and Company
  • 20.4. Berry Global, Inc.
  • 20.5. Catalent (US)
  • 20.6. CCL Industries, Inc.
  • 20.7. Comar, LLC
  • 20.8. Drug Plastics Group
  • 20.9. Gerresheimer AG
  • 20.10. International Paper
  • 20.11. Owens Illinois, Inc.
  • 20.12. Schott AG
  • 20.13. SGD Pharma
  • 20.14. Vetter Pharma International
  • 20.15. West Pharmaceutical Services, Inc.
  • 20.16. WestRock Company
  • 20.17. Other Prominent Players